Title: Intestinal DGAT1 deficiency reduces postprandial triglyceride and retinyl ester excursions by inhibiting chylomicron secretion and delaying gastric emptying.
Journal: Journal of lipid research 20121101
Title: Glucagon-like peptide-1(1-37) can enhance blood glucose homeostasis in mice.
Journal: Regulatory peptides 20121010
Title: Postconditioning with curaglutide, a novel GLP-1 analog, protects against heart ischemia-reperfusion injury in an isolated rat heart.
Journal: Regulatory peptides 20121010
Title: Glucagon-like peptide 1 receptor plays an essential role in geniposide attenuating lipotoxicity-induced β-cell apoptosis.
Journal: Toxicology in vitro : an international journal published in association with BIBRA 20121001
Title: GLP-1 receptor antagonist exendin-(9-39) elevates fasting blood glucose levels in congenital hyperinsulinism owing to inactivating mutations in the ATP-sensitive K+ channel.
Journal: Diabetes 20121001
Title: The role of endogenous incretin secretion as amplifier of glucose-stimulated insulin secretion in healthy subjects and patients with type 2 diabetes.
Journal: Diabetes 20120901
Title: Is endogenous GLP-1 the only important enhancer of glucose-induced insulin secretion in type 2 diabetes?
Journal: Diabetes 20120901
Title: Receptor identification and physiological characterisation of glucagon-like peptide-2 in the rat heart.
Journal: Nutrition, metabolism, and cardiovascular diseases : NMCD 20120601
Title: Roux-en-Y gastric bypass in rats increases sucrose taste-related motivated behavior independent of pharmacological GLP-1-receptor modulation.
Journal: American journal of physiology. Regulatory, integrative and comparative physiology 20120315
Title: Self-inducible secretion of glucagon-like peptide-1 (GLP-1) that allows MIN6 cells to maintain insulin secretion and insure cell survival.
Journal: Molecular and cellular endocrinology 20120226
Title: Synthesis and evaluation of [18F]exendin (9-39) as a potential biomarker to measure pancreatic β-cell mass.
Journal: Nuclear medicine and biology 20120201
Title: Glucagon-like peptide-1 modulates neurally evoked mucosal chloride secretion in guinea pig small intestine in vitro.
Journal: American journal of physiology. Gastrointestinal and liver physiology 20120201
Title: Pancreatic GLP-1 receptor activation is sufficient for incretin control of glucose metabolism in mice.
Journal: The Journal of clinical investigation 20120103
Title: Glucagon-like peptides 1 and 2 and vasoactive intestinal peptide are neuroprotective on cultured and mast cell co-cultured rat myenteric neurons.
Journal: BMC gastroenterology 20120101
Title: The common hepatic branch of the vagus is not required to mediate the glycemic and food intake suppressive effects of glucagon-like-peptide-1.
Journal: American journal of physiology. Regulatory, integrative and comparative physiology 20111101
Title: Glucagon-like peptide 1 receptors in nucleus accumbens affect food intake.
Journal: The Journal of neuroscience : the official journal of the Society for Neuroscience 20111012
Title: A physiological role of glucagon-like peptide-1 receptors in the central nervous system of Suncus murinus (house musk shrew).
Journal: European journal of pharmacology 20111001
Title: Native incretins prevent the development of atherosclerotic lesions in apolipoprotein E knockout mice.
Journal: Diabetologia 20111001
Title: Foetal proglucagon processing in relation to adult appetite control: lessons from a transplantable rat glucagonoma with severe anorexia.
Journal: Diabetes, obesity & metabolism 20111001
Title: Both stimulation of GLP-1 receptors and inhibition of glycogenolysis additively contribute to a protective effect of oral miglitol against ischaemia-reperfusion injury in rabbits.
Journal: British journal of pharmacology 20110901
Title: Peripheral and central GLP-1 receptor populations mediate the anorectic effects of peripherally administered GLP-1 receptor agonists, liraglutide and exendin-4.
Journal: Endocrinology 20110801
Title: DPP4 deficiency preserves cardiac function via GLP-1 signaling in rats subjected to myocardial ischemia/reperfusion.
Journal: Naunyn-Schmiedeberg's archives of pharmacology 20110801
Title: Endogenously released GLP-1 is not sufficient to alter postprandial glucose regulation in the dog.
Journal: Endocrine 20110601
Title: Antidiabetic actions of endogenous and exogenous GLP-1 in type 1 diabetic patients with and without residual β-cell function.
Journal: Diabetes 20110501
Title: Involvement of endogenous glucagon-like peptide-1 in regulation of gastric motility and pancreatic endocrine secretion.
Journal: Scandinavian journal of gastroenterology 20110401
Title: Hyperphagia and increased fat accumulation in two models of chronic CNS glucagon-like peptide-1 loss of function.
Journal: The Journal of neuroscience : the official journal of the Society for Neuroscience 20110309
Title: Metformin regulates the incretin receptor axis via a pathway dependent on peroxisome proliferator-activated receptor-α in mice.
Journal: Diabetologia 20110201
Title: New aspects of an old drug: metformin as a glucagon-like peptide 1 (GLP-1) enhancer and sensitiser.
Journal: Diabetologia 20110201
Title: Endogenous GLP-1 regulates postprandial glycemia in humans: relative contributions of insulin, glucagon, and gastric emptying.
Journal: The Journal of clinical endocrinology and metabolism 20110101
Title: Glucagon-like peptide-1 enhances cardiac L-type Ca2+ currents via activation of the cAMP-dependent protein kinase A pathway.
Journal: Cardiovascular diabetology 20110101
Title: Glucagon receptor antagonist-mediated improvements in glycemic control are dependent on functional pancreatic GLP-1 receptor.
Journal: American journal of physiology. Endocrinology and metabolism 20101001
Title: Peripheral motor action of glucagon-like peptide-1 through enteric neuronal receptors.
Journal: Neurogastroenterology and motility : the official journal of the European Gastrointestinal Motility Society 20100601
Title: Glucagon-like peptide (GLP)-1(9-36)amide-mediated cytoprotection is blocked by exendin(9-39) yet does not require the known GLP-1 receptor.
Journal: Endocrinology 20100401
Title: Endogenous glucagon-like peptide-1 slows gastric emptying in healthy subjects, attenuating postprandial glycemia.
Journal: The Journal of clinical endocrinology and metabolism 20100101
Title: Glucagon-like peptide-1 protects mesenteric endothelium from injury during inflammation.
Journal: Peptides 20090901
Title: Hypothalamic injection of oxyntomodulin suppresses circulating ghrelin-like immunoreactivity.
Journal: Endocrinology 20090801
Title: GLP-1 regulates gastroduodenal motility involving cholinergic pathways.
Journal: Neurogastroenterology and motility : the official journal of the European Gastrointestinal Motility Society 20090601
Title: Hindbrain cocaine- and amphetamine-regulated transcript induces hypothermia mediated by GLP-1 receptors.
Journal: The Journal of neuroscience : the official journal of the Society for Neuroscience 20090527
Title: Reappraisal of the intravenous glucose tolerance index for a simple assessment of insulin sensitivity in mice.
Journal: American journal of physiology. Regulatory, integrative and comparative physiology 20090501
Title: [A novel cell model targeted on GLP-1 receptor for application to anti-diabetic candidates screening].
Journal: Yao xue xue bao = Acta pharmaceutica Sinica 20090301
Title: Peripheral GLP-1 gastroprotection against ethanol: the role of exendin, NO, CGRP, prostaglandins and blood flow.
Journal: Regulatory peptides 20090108
Title: Regulation of islet hormone release and gastric emptying by endogenous glucagon-like peptide 1 after glucose ingestion.
Journal: The Journal of clinical endocrinology and metabolism 20081201
Title: GLP-1 and related peptides cause concentration-dependent relaxation of rat aorta through a pathway involving KATP and cAMP.
Journal: Archives of biochemistry and biophysics 20081015
Title: Brain glucagon-like peptide 1 signaling controls the onset of high-fat diet-induced insulin resistance and reduces energy expenditure.
Journal: Endocrinology 20081001
Title: Exendin-(9-39) corrects fasting hypoglycemia in SUR-1-/- mice by lowering cAMP in pancreatic beta-cells and inhibiting insulin secretion.
Journal: The Journal of biological chemistry 20080919
Title: Exenatide can reduce glucose independent of islet hormones or gastric emptying.
Journal: American journal of physiology. Endocrinology and metabolism 20080801
Title: GLP-1 (9-36) amide, cleavage product of GLP-1 (7-36) amide, is a glucoregulatory peptide.
Journal: Obesity (Silver Spring, Md.) 20080701
Title: Glucagon-like peptide-1 modulates synaptic transmission to identified pancreas-projecting vagal motoneurons.
Journal: Peptides 20071101
Title: Central effects of glucagon-like peptide-1 on cold-restraint stress-induced gastric mucosal lesions.
Journal: The Turkish journal of gastroenterology : the official journal of Turkish Society of Gastroenterology 20070901
Title: Effects of antidiabetic drugs on dipeptidyl peptidase IV activity: nateglinide is an inhibitor of DPP IV and augments the antidiabetic activity of glucagon-like peptide-1.
Journal: European journal of pharmacology 20070730
Title: Mediators of glucagon-like peptide 2-induced blood flow: responses in different vascular sites.
Journal: Regulatory peptides 20070705
Title: Action of GLP-1 (7-36) amide and exendin-4 on Suncus murinus (house musk shrew) isolated ileum.
Journal: European journal of pharmacology 20070702
Title: Glucagon-like peptide-1 excites pancreas-projecting preganglionic vagal motoneurons.
Journal: American journal of physiology. Gastrointestinal and liver physiology 20070601
Title: The action of GLP-1 and exendins upon glucose transport in normal human adipocytes, and on kinase activity as compared to morbidly obese patients.
Journal: International journal of molecular medicine 20070601
Title: Metabolic effects of sub-chronic ablation of the incretin receptors by daily administration of (Pro3)GIP and exendin(9-39)amide in obese diabetic (ob/ob) mice.
Journal: Biological chemistry 20070201
Title: Dual-acting peptide with prolonged glucagon-like peptide-1 receptor agonist and glucagon receptor antagonist activity for the treatment of type 2 diabetes.
Journal: The Journal of endocrinology 20070201
Title: Glucagon like peptide-1 accelerates colonic transit via central CRF and peripheral vagal pathways in conscious rats.
Journal: Autonomic neuroscience : basic & clinical 20070130
Title: Endogenous glucagon-like peptide 1 controls endocrine pancreatic secretion and antro-pyloro-duodenal motility in humans.
Journal: Gut 20060201
Title: Brain glucagon-like peptide-1 increases insulin secretion and muscle insulin resistance to favor hepatic glycogen storage.
Journal: The Journal of clinical investigation 20051201
Title: GLP-1 signalling and effects on glucose metabolism in myocytes from type 2 diabetic patients.
Journal: International journal of molecular medicine 20051001
Title: Effects of glucagon-like peptide-1 and exendins on kinase activity, glucose transport and lipid metabolism in adipocytes from normal and type-2 diabetic rats.
Journal: Journal of molecular endocrinology 20050801
Title: Intravenous infusion of glucagon-like peptide-1 potently inhibits food intake, sham feeding, and gastric emptying in rats.
Journal: American journal of physiology. Regulatory, integrative and comparative physiology 20050601
Title: Chronic treatment with exendin(9-39)amide indicates a minor role for endogenous glucagon-like peptide-1 in metabolic abnormalities of obesity-related diabetes in ob/ob mice.
Journal: The Journal of endocrinology 20050501
Title: Contraction induced by glicentin on smooth muscle cells from the human colon is abolished by exendin (9-39).
Journal: Neurogastroenterology and motility : the official journal of the European Gastrointestinal Motility Society 20050401
Title: Pancreatic beta-cells expressing GLP-1 are resistant to the toxic effects of immunosuppressive drugs.
Journal: Journal of molecular endocrinology 20050401
Title: Effect of GLP-1 on glucose transport and its cell signalling in human myocytes.
Journal: Regulatory peptides 20050330
Title: Glucagon-like peptide-1 relaxes rat conduit arteries via an endothelium-independent mechanism.
Journal: Regulatory peptides 20050215
Title: Glucagon-like peptide 1 excites hypocretin/orexin neurons by direct and indirect mechanisms: implications for viscera-mediated arousal.
Journal: The Journal of neuroscience : the official journal of the Society for Neuroscience 20040915
Title: Lys9 for Glu9 substitution in glucagon-like peptide-1(7-36)amide confers dipeptidylpeptidase IV resistance with cellular and metabolic actions similar to those of established antagonists glucagon-like peptide-1(9-36)amide and exendin (9-39).
Journal: Metabolism: clinical and experimental 20040201
Title: The positive charge at Lys-288 of the glucagon-like peptide-1 (GLP-1) receptor is important for binding the N-terminus of peptide agonists.
Journal: FEBS letters 20031023
Title: Effects of prolonged exendin-4 administration on entero-insular axis of normal and streptozotocin-induced diabetic rats.
Journal: International journal of molecular medicine 20030601
Title: Effects of the novel (Pro3)GIP antagonist and exendin(9-39)amide on GIP- and GLP-1-induced cyclic AMP generation, insulin secretion and postprandial insulin release in obese diabetic (ob/ob) mice: evidence that GIP is the major physiological incretin.
Journal: Diabetologia 20030201
Title: Local, exendin-(9-39)-insensitive, site of action of GLP-1 in canine ileum.
Journal: American journal of physiology. Gastrointestinal and liver physiology 20020901
Title: Glucagon-like peptide-1 (GLP-1) and glucose metabolism in human myocytes.
Journal: The Journal of endocrinology 20020601
Title: Effects of intracerebroventricular injection of glucagon like peptide-1 and its related peptides on serotonin metabolism and on levels of amino acids in the rat hypothalamus.
Journal: Brain research 20020301
Title: Assessment of the role of interstitial glucagon in the acute glucose secretory responsiveness of in situ pancreatic beta-cells.
Journal: Diabetes 20020301
Title: Resistance of succinic acid dimethyl ester insulinotropic action to exendin (9-39) amide.
Journal: Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme 20020101
Title: Glucose competence of the hepatoportal vein sensor requires the presence of an activated glucagon-like peptide-1 receptor.
Journal: Diabetes 20010801
Title: Suppression by exendin(9-39)amide of glucagon-like peptide-1 insulinotropic action in rats infused with dimethyl ester of succinic acid.
Journal: Endocrine 20010801
Title: Neuropeptide regulation of feeding in catfish, Ictalurus punctatus: a role for glucagon-like peptide-1 (GLP-1)?
Journal: Comparative biochemistry and physiology. Part B, Biochemistry & molecular biology 20010601
Title: Calabria AC, et al. GLP-1 receptor antagonist exendin-(9-39) elevates fasting blood glucose levels in congenital owing to inactivating mutations in the ATP-sensitive K+ channel. Diabetes. 2012 Oct;61(10):2585-91.
Title: De León DD, et al. Exendin-(9-39) corrects fasting hypoglycemia in SUR-1-/- mice by lowering cAMP in pancreatic beta-cells and inhibiting secretion. J Biol Chem. 2008 Sep 19;283(38):25786-93.
